Literature DB >> 16036738

The association between knowledge and attitudes about genetic testing for cancer risk in the United States.

Abigail Rose1, Nikki Peters, Judy A Shea, Katrina Armstrong.   

Abstract

Attitudes about genetic testing are likely to be an important determinant of uptake of predictive genetic tests among the general public. Several prior studies have suggested that positive attitudes about genetic testing may be inversely related to knowledge about genetic testing. We conducted a random-digit-dialing (RDD) telephone survey of 961 adults in the continental United States to determine the associations among knowledge of, attitudes about, and perceptions of eligibility for genetic testing for cancer risk. Knowledge about genetic testing for cancer risk was generally high, with a mean accuracy score of 72%. Attitudes about genetic testing for cancer risk were also generally positive, with 87% of respondents reporting genetic testing for cancer risk would be used to help doctors manage their health care and 85% to help scientists find cures for diseases. In contrast, 58% of respondents thought genetic testing for cancer risk would be used to prevent them from getting health insurance and 31% to allow the government to label groups as inferior. Twenty-nine percent of respondents thought they were currently eligible for testing. After adjustment for sociodemographic characteristics and family cancer history, higher knowledge was correlated with more positive attitudes about testing, but not with negative attitudes or perceptions of testing eligibility. Family history was positively associated with perceptions of eligibility (OR 3.49, 95% CI 2.36-5.18), and higher levels of education were inversely associated with perceptions of eligibility (OR 0.55, 95% CI 0.32-0.94 for comparison of college or higher vs. less than high school). These results suggest that most members of the general public are knowledgeable and have positive attitudes about genetic testing for cancer risk and that greater knowledge is correlated with more positive attitudes about the benefits of testing.

Entities:  

Mesh:

Year:  2005        PMID: 16036738     DOI: 10.1080/10810730590950039

Source DB:  PubMed          Journal:  J Health Commun        ISSN: 1081-0730


  31 in total

1.  Genetic testing and counseling for hereditary neurological diseases in Mali.

Authors:  Katherine Gloria Meilleur; Souleymane Coulibaly; Moussa Traoré; Guida Landouré; Alison La Pean; Modibo Sangaré; Fanny Mochel; Siona Traoré; Kenneth H Fischbeck; Hae-Ra Han
Journal:  J Community Genet       Date:  2011-02-22

2.  Korean American Women and Mammogram Uptake.

Authors:  Eunice E Lee; Karabi Nandy; Laura Szalacha; HanJong Park; Kyeung Mi Oh; Jongwon Lee; Usha Menon
Journal:  J Immigr Minor Health       Date:  2016-02

Review 3.  Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value.

Authors:  Kathryn A Phillips; Su-Ying Liang; Stephanie Van Bebber
Journal:  Curr Opin Mol Ther       Date:  2008-06

4.  Public attitudes towards genomic risk profiling as a component of routine population screening.

Authors:  S G Nicholls; B J Wilson; S M Craigie; H Etchegary; D Castle; J C Carroll; B K Potter; L Lemyre; J Little
Journal:  Genome       Date:  2013-08-31       Impact factor: 2.166

Review 5.  Ethical issues of predictive genetic testing for diabetes.

Authors:  Susanne B Haga
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

6.  Genetic knowledge and attitudes of parents of children with congenital heart defects.

Authors:  Sara M Fitzgerald-Butt; Jennifer Klima; Kelly Kelleher; Deena Chisolm; Kim L McBride
Journal:  Am J Med Genet A       Date:  2014-09-24       Impact factor: 2.802

7.  Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample.

Authors:  Sara J Knight; Ateesha F Mohamed; Deborah A Marshall; Uri Ladabaum; Kathryn A Phillips; Judith M E Walsh
Journal:  Med Decis Making       Date:  2015-01-14       Impact factor: 2.583

8.  Valuations of genetic test information for treatable conditions: the case of colorectal cancer screening.

Authors:  Vikram Kilambi; F Reed Johnson; Juan Marcos González; Ateesha F Mohamed
Journal:  Value Health       Date:  2014-11-06       Impact factor: 5.725

9.  Public attitudes towards genetic testing revisited: comparing opinions between 2002 and 2010.

Authors:  Lidewij Henneman; Eric Vermeulen; Carla G van El; Liesbeth Claassen; Danielle R M Timmermans; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2012-12-19       Impact factor: 4.246

10.  Public trust in genomic risk assessment for type 2 diabetes mellitus.

Authors:  Rachel Mills; William Barry; Susanne B Haga
Journal:  J Genet Couns       Date:  2013-12-03       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.